08/12/13 -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing vaccines to prevent and treat HIV/AIDS, announced its financial results for the six months ended June 30, 2013 and provided a clinical development update. GeoVax reported ...
http://www.sys-con.com/node/2756197
http://www.sys-con.com/node/2756197
No comments:
Post a Comment